Patients with recurrent/metastatic HER2-positive breast cancer experienced durable response and manageable safety from KN026-docetaxel combination therapy. Lerociclib plus fulvestrant demonstrated a ...

Seven-year follow-up data of a multicenter, randomized phase 2 study evaluating the treatment of melanoma brain metastases shows ipilimumab plus nivolumab is an effective long-term care option. First ...

NEW YORK - A Ludwig Cancer Research study has identified a key barrier to the efficacy of a promising combination of ...

and Associate Program Director of the Hematology/Oncology Fellowship Training Program at Fox Chase Cancer Center describes the clues to HER2 discordance between the primary tumor and brain ...

Experts discuss how, nearly half of patients diagnoses with HER-2 positive metastatic brain cancer do develop brain metastasis. It is thought that larger molecule treatments such as the monoclonal ant ...

A novel intranasal drug delivery system for brain tumors is advancing clinical trials in India, offering a non-invasive, ...

Teacher Retirement System of Texas lifted its stake in shares of Nuvalent, Inc. (NASDAQ:NUVL – Free Report) by 43.1% during the fourth quarter, according to its most recent disclosure with the ...

A proposed ballot measure in California named after Luigi Mangione, the suspected killer of UnitedHealthcare CEO Brian ...

Jan. 28, 2025 — A new study shows that asymptomatic brain metastasis is more common in stage 4 breast cancer patients than previously believed. The study suggests that doctors may need to ...

Delve into the kinase inhibitors' diverse landscape, from cancer breakthroughs to autoimmune disease innovations.

Investment analysts at HC Wainwright issued their FY2029 earnings estimates for Plus Therapeutics in a research report issued to clients and investors on Friday, March 28th. HC Wainwright analyst S.

A young Ghanaian lady has been diagnosed with brain tumour and urgently needs support for treatment. She has appealed to ...